Bright Minds Biosciences (DRUG) Profit After Tax (2020 - 2026)
Bright Minds Biosciences (DRUG) reported Profit After Tax of -$7.6 million for Q1 2026, down 483.85% on a YoY basis from $2.0 million in Q1 2025, and down 40.59% quarter-over-quarter from -$5.4 million in Q4 2025.
Bright Minds Biosciences (DRUG) Profit After Tax (2020 - 2026) Analysis & Trends
Bright Minds Biosciences has reported Profit After Tax for 7 years, with the latest figure at -$7.6 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 483.85% year-over-year to -$7.6 million; the trailing twelve-month figure through Mar 2026 stood at -$19.8 million (down 818.19% YoY), and the FY2025 full-year result was -$8.9 million, down 332.64% from the prior year.
- Profit After Tax for Q1 2026 stood at -$7.6 million, down from -$5.4 million in the prior quarter.
- The five-year high for Profit After Tax was $3.5 million in Q1 2022, with the low at -$7.6 million in Q1 2026.
- Historically, Profit After Tax has averaged -$953184.1 across 5 years, with a median of -$1.1 million in 2023.
- The largest YoY upside for Profit After Tax was 566.35% in 2025 against a maximum downside of 15375.94% in 2025.
- Bright Minds Biosciences' Profit After Tax stood at -$1.7 million in 2022, then rose by 28.09% to -$1.2 million in 2023, then jumped by 102.87% to $35513.3 in 2024, then plunged by 15375.94% to -$5.4 million in 2025, then plunged by 40.59% to -$7.6 million in 2026.
- The last three Profit After Tax figures came in at -$7.6 million (Q1 2026), -$5.4 million (Q4 2025), and -$3.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -56.74 Mn |
| 10 | Bright Minds Biosciences | 16.28 Bn | 16.22 Bn | - | -7.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.63 Mn |
| Dec 31, 2025 | -5.42 Mn |
| Sep 30, 2025 | -2.97 Mn |
| Jun 30, 2025 | -3.78 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 35,513.28 |
| Sep 30, 2024 | 566,973.56 |
| Jun 30, 2024 | 168,091.41 |
| Mar 31, 2024 | -426,077.62 |
| Dec 31, 2023 | -1.24 Mn |
| Sep 30, 2023 | -1.07 Mn |
| Jun 30, 2023 | -1.09 Mn |
| Mar 31, 2023 | -1.52 Mn |
| Dec 31, 2022 | -1.72 Mn |
| Sep 30, 2022 | 2.27 Mn |
| Jun 30, 2022 | 2.09 Mn |
| Mar 31, 2022 | 3.54 Mn |
| Dec 31, 2021 | 3.85 Mn |
| Sep 30, 2021 | -11.47 Mn |
| Jun 30, 2021 | 2.87 Mn |